Stephen Kilmer | Investor Relations |
Daniel White | Chief Executive Officer |
Glen Noronha | Chief Scientific Officer |
Charlie Deignan | Chief Financial Officer |
Brion Raymond | Chief Commercial Officer |
Nick Rubino | Stifel |
Serge Belanger | Needham |
Liana Moussatos | Wedbush |
Good day, ladies and gentlemen and welcome to the Q2 2018 Clearside Biomedical Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] I would now like to introduce your host for today’s conference, Mr. Steve Kilmer of Investor Relations.